akhatri

The Department of Health and Social Care (DHSC) has confirmed the Serious Shortage Protocol (SSP087) for Ramipril 1.25mg capsules will expire at 23:59pm Friday 30th October 2026. After this date, any prescriptions for Ramipril 1.25mg capsules must be dispensed in accordance with the prescription. Top tips for SSP claims Where available, use the claim amend [...]

The post Expiry of SSP087 Ramipril 1.25mg capsules appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Recall: Mynzepli 40 mg/mL solution for injection in pre-filled syringe (Advanz Pharma Limited). Drug alert number: EL(26)A/44 Date issued: 29 October 2026 Advanz Pharma Limited are recalling specified batches of Mynzepli 40 mg/mL solution for injection in pre-filled syringe as a precautionary measure. DMRC reference number: DMRC-41252013 Company name: Advanz Pharma Limited [...]

The post MHRA Class 2 Medicines Recall: Mynzepli 40 mg/mL solution for injection in pre-filled syringe (Advanz Pharma Limited) appeared first on Community Pharmacy England.

The Medicines and Healthcare products Regulatory Agency (MHRA) has announced that the annual #MedSafetyWeek campaign is taking place from 2 to 8 November 2026 to promote the importance of reporting side effects from medicines and medical device incidents. This year’s theme is ‘Side effects: don’t ignore them, report them!’ The Yellow Card scheme relies on [...]

The post MHRA Drug Safety Update: #MedSafetyWeek (2 to 8 November 2026) appeared first on Community Pharmacy England.

Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 November 2026. Generic drug name (dm+d descriptor) Brand and/or manufacturer Pack Size Special container Ipratropium bromide 250micrograms/1ml nebuliser liquid unit dose vials Atrovent® 250micrograms/1ml nebuliser liquid UDVs (Boehringer [...]

The post 3 products re-classified as special containers from November 2026 appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Recall: Pedmarqsi 80 mg/mL solution for infusion (Norgine Pharmaceuticals Limited) Drug alert number: EL(26)A/42 Date issued: 12 October 2026 Norgine Pharmaceuticals Limited is recalling the batches listed in the table due to risk of particulate matter being present in the product identified during routine stability investigations. DMRC reference number: DMRC-41054154 Company name: [...]

The post MHRA Class 2 Medicines Recall: Pedmarqsi 80 mg/mL solution for infusion (Norgine Pharmaceuticals Limited) appeared first on Community Pharmacy England.